Clinical updates, including trial initiations, enrollment status and data readouts and publications:  Abbvie, Abcuro, Adiso, Amgen, Aquestive, Ascendis, Caliway, Canbridge, Celldex, Coave, Glyscend, Horizon, Kahr, Nacuity, Onconano, Pathalys, Precision, Rayzebio, Sanofi, Selecta, Snipr, Travere, Xencor.